Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Jail and overdose: assessing the community impact of incarceration on overdose

This study examined the overall impact of jail incarceration on overdose, the specific hazard for those booked on a syringe-related charge and the proportion of all overdose decedents in the community
Original research | 2022
Overdose, Mortality, About PWUD, Legal system/law enforcement, Illegal drugs

Making Addiction Treatment More Realistic And Pragmatic: The Perfect Should Not Be The Enemy Of The Good

Commentary | 2022
Overdose, Clinical guidance, Harm reduction, Policy/Regulatory, Hesitancy of prescribers , About prescribers, Illegal drugs, SCS/OPS

More than saving lives: Qualitative findings of the UNODC/WHO Stop Overdose Safely (S-O-S) project

The Stop Overdose Safely (S-O-S) initiative—developed in compliance with WHO guidelines—aims to prevent opioid overdose deaths.
Original research | 2022
Overdose, Mortality, Harm reduction, About PWUD, Barriers and enablers, Legal system/law enforcement, Illegal drugs, Peer/PWLLE program involvement

Nonjudgmental acceptance: Associations with substance-related cue reactivity in adults with substance use disorders and posttraumatic stress

The present investigation examined the predictive utility of nonjudgmental acceptance, a facet of mindfulness defined as the ability to remain aware and nonevaluative about internal experience, in ter
Original research | 2021
About PWUD, Outcomes, Illegal drugs, Mental health

Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial

Pharmacy administration and dispensing of methadone for methadone maintenance treatment (MMT) can expand treatment access for opioid use disorder (OUD).

Original research | 2022
About pharmacists, About PWUD, Outcomes, Substitution/OAT, Diversion, Carries/take-home doses

Racial disparities in linkage to care among patients with substance use disorders

We describe success of peer support specialists in recruiting SUD patients into treatment, with attention to racial disparities in linkage to care.
Original research | 2021
Equity, About PWUD, Outcomes, Peer/PWLLE program involvement, Transitions in care/treatment, Hospitals

Safer Smoking Supplies

Tips for safer smoking
Handout | 2020
Harm reduction, Wrap-around services, Illegal drugs

Social recovery in substance use disorder: A metasynthesis of qualitative studies

The aim here has been to identify and synthesise the qualitative research examining the process of social recovery from a first-person perspective and how social communities assist in this process.
Lit review | 2022
Wrap-around services, About PWUD, Social services, Barriers and enablers, Social benefits

Substance-Use-Related Language, Stigma & Harm Reduction

Archived webinar | 2021
Equity, Advocacy, About PWUD, Illegal drugs, Peer/PWLLE program involvement, Stigma

The Covered Light

Video | 2021
Overdose, Advocacy, About PWUD, Illegal drugs, Substitution/OAT, SCS/OPS

The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex

Race/ethnicity and sex disparities in substance use and substance use treatment completion are well documented in the literature.
Original research | 2021
Wrap-around services, Equity, About PWUD, Substitution/OAT, Sex/Gender

The missing ‘I’ in drug research and the epistemic justice of disclosure

While there is a growing body of ethnography with people who use drugs (PWUD), researchers who are themselves out as drug users—and their unofficial expertise—are largely absent.
Commentary | 2021
Equity, Advocacy, About PWUD, Illegal drugs, Peer/PWLLE program involvement

Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005-2019

There is evidence of change in recent substance type associated with morbidity and mortality.
Original research | 2022
Overdose, Mortality, Harm reduction, About PWUD, Illegal drugs, Stimulants

Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence

The idea that cannabis is a ‘gateway drug’ to more harmful substances such as opioids is highly controversial, yet has substantially impacted policy, education and how we conceptualize substance use.
Lit review | 2022
Policy/Regulatory, About PWUD, Illegal drugs

Wounds Canada

Webpage | 2022
Wrap-around services, Advocacy, About prescribers, Social services, Chronic pain, Injecting drugs

Additional Insights: Through the Autism Lens

Handout | 2021
Peer/PWLLE program involvement

Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions

To assess whether naloxone prescribing in clinical contexts targeted pain patients most at risk for opioid overdose.
Original research | 2022
Overdose, Mortality, Harm reduction, About prescribers, Outcomes, Chronic pain

Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19

Audiovisual telehealth has been shown to be effective for buprenorphine maintenance treatment prior to COVID-19, but use of telehealth for buprenorphine treatment initiation, and the use of audio-only
Original research | 2022
Equity, About prescribers, Substitution/OAT, Digital health

Chronic pain, prescribed opioids and overdose risk: a qualitative exploration of the views of affected individuals and family members

Explored how individuals and family members perceive the issue of overdose in relation to opioid analgesics, and their views of overdose prevention and potential interventions.
Original research | 2022
Overdose, Safer supply, About PWUD, Chronic pain

Cost-Effectiveness and Guidelines for Opioid Substitution Treatment

Examine the cost-effectiveness of SROM, hydromorphone, diacetylmorphine, and fentanyl in opioid use disorder, and describe the evidence-based guidelines for the use of these treatments
Lit review | 2021
Clinical guidance, Evidence base, Safer supply, About prescribers, Substitution/OAT

Refine Your Search

Keywords
Format
Region